TheraGenetics Appoints Mark Kesti As Vice President Of Sales For Galt Medical And Needletech Products

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Theragenics Corporation®, a leading medical device company serving the surgical products and prostate cancer treatment markets, today announced that Mark Kesti has been hired as Vice President of Sales for its Galt Medical and NeedleTech Products companies. In this role, Mark will lead all sales activities for Galt and NeedleTech including contract manufacturing, OEM and dealer sales for both companies.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC